Company Overview - Zealand Pharma A/S is a biotechnology company focused on advancing medicines for obesity and metabolic health, leveraging over 25 years of peptide R&D expertise and a proprietary data platform utilizing advanced data-driven and AI/ML approaches [2][3] - The company has more than ten drug candidates that have entered clinical development, with two products already on the market and three candidates in late-stage development [3] Annual General Meeting (AGM) Details - The Annual General Meeting for Zealand Pharma will take place on Thursday, March 26, 2026, at 03:00 PM CET / 9:00 AM ET, and will be conducted as a hybrid meeting allowing both electronic and in-person participation [1][2] - The meeting will be hosted electronically via a virtual meeting portal by Computershare A/S, with a physical location at the company's registered office in Søborg, Denmark [2]
Zealand Pharma convenes its Annual General Meeting 2026
Globenewswire·2026-02-19 13:00